GlassScriptPhysician profile
Melissa Philip
NPI 1477930717
$987.41
in general payments reported to CMS, 2019-2025
25 companies · $116 in 2025
The $116 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2020: $40.25 · 2021: $55.96 · 2022: $407 · 2023: $153 · 2024: $110 · 2025: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $379.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $200.50 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $137.87 | 2022-2023 | |
| Lilly USA, LLC | $86.02 | 2020-2023 | Jardiance, Emgality |
| Abbott Laboratories | $82.94 | 2022-2025 | Freestyle Libre 3 |
| Amgen INC. | $71.54 | 2019-2025 | Repatha, Otezla |
| Biohaven Pharmaceutical Holding Company LTD. | $40.41 | 2022 | |
| Pfizer INC. | $37.17 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $33.64 | 2019-2024 | Capvaxive, Gardasil, Gardasil 9 |
| Medtronic, INC. | $32.34 | 2022-2023 | Venaseal |
| Bayer Healthcare Pharmaceuticals INC. | $27.31 | 2021-2022 | |
| Dexcom, INC. | $24.56 | 2025 | Dexcom G6 Transmitter |
| Amarin Pharma, INC. | $22.32 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.58 | 2022 | |
| Glaxosmithkline, LLC. | $19.19 | 2023 | Trelegy Ellipta, Arexvy, Shingrix |
| Renalytix Ai, INC. | $17.53 | 2024 | Kidneyintelx Blood Collection Convenience Kit |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $15.95 | 2024 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $15.15 | 2022 | |
| Vivus LLC | $14.99 | 2022 | |
| Currax Pharmaceuticals LLC | $14.20 | 2022 | |
| Shire North American Group INC | $14.09 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $13.38 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.77 | 2022 | |
| Althera Pharmaceuticals LLC | $11.56 | 2022 | |
| Sanofi Pasteur INC. | $11.34 | 2019 | |
| Novartis Pharmaceuticals Corporation | $11.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Philip listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.